<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="several repurposed candidates in the drug development pipeline. Galidesivir and" exact="Sofosbuvir" post="are both nucleoside analog antivirals originally used to treat"/>
 <result pre="for the treatment of YF [95, 96]. Both Galidesivir and" exact="Sofosbuvir" post="were found to inhibit YF replication in vitro and"/>
 <result pre="patients presenting with acute liver failure were treated off-label with" exact="Sofosbuvir" post="for a week as compassionate use and displayed marked"/>
 <result pre="we?Trends Microbiol2018261086587610.1016/j.tim.2018.04.00429759926 95.SacramentoCQde MeloGRde FreitasCSRochaNHoelzLVMirandaMet al.The clinically approved antiviral drug" exact="sofosbuvir" post="inhibits Zika virus replicationSci Rep201774092010.1038/srep4092028098253 96.XuHTColby-GerminarioSPHassounahSAFogartyCOsmanNPalanisamyNHanYOliveiraMQuanYWainbergMAEvaluation of Sofosbuvir (beta-D-2â€²-deoxy-2â€²-alpha-fluoro-2â€²-beta-C-methyluridine)"/>
 <result pre="antiviral drug sofosbuvir inhibits Zika virus replicationSci Rep201774092010.1038/srep4092028098253 96.XuHTColby-GerminarioSPHassounahSAFogartyCOsmanNPalanisamyNHanYOliveiraMQuanYWainbergMAEvaluation of" exact="Sofosbuvir" post="(beta-D-2â€²-deoxy-2â€²-alpha-fluoro-2â€²-beta-C-methyluridine) as an inhibitor of dengue virus replicationSci Rep201771634510.1038/s41598-017-06612-228740124"/>
 <result pre="98.de FreitasCSHigaLMSacramentoCQFerreiraACReisPADelvecchioRMonteiroFLBarbosa-LimaGJames WestgarthHVieiraYRMattosMRochaNHoelzLVBLemeRPPBastosMML. RodriguesGOM. LopesCEQueiroz-JuniorCMLimaCXCostaVVTeixeiraMMBozzaFABozzaPTBoechatNTanuriASouzaTMLYellow fever virus is susceptible to" exact="sofosbuvir" post="both in vitro and in vivoPLoS Negl Trop Dis2019131e000707210.1371/journal.pntd.000707230699122"/>
</results>
